(Q34686858)

English

Predictive effect of XPA and XPD polymorphisms on survival of advanced NSCLC patients treated with platinum-based chemotherapy: a three-dimensional (3-D), polyacrylamide gel-based DNA microarray method

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Predictive effect of XPA and XPD polymorphisms on survival of advanced NSCLC patients treated with platinum-based chemotherapy: a three-dimensional (3-D), polyacrylamide gel-based DNA microarray method (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

polyacrylamide gel

1 reference

based on heuristic

inferred from title

8

object named as

Baoan Chen

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Hongyan Cheng

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Qin Qin

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Xinchen Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Fan Li

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ning Sun

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lu Cheng

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Zuhong Lu

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

24 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Technology in Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

473-482

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Estimation and projection of the national profile of cancer mortality in China: 1991-2005

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

An interview of Professor Stephen Abrahamson

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

The treatment of advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Molecular mechanisms of resistance and toxicity associated with platinating agents

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

The role of p53 in treatment responses of lung cancer

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Sequential assembly of the nucleotide excision repair factors in vivo

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Multiple protein-protein interactions by RNA polymerase I-associated factor PAF49 and role of PAF49 in rRNA transcription

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Influence of DNA damage and repair upon the risk of treatment related leukemia

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

XPA A23G polymorphism and susceptibility to cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Predicting drug response and toxicity based on gene polymorphisms

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin/gemcitabine-treated advanced non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy.

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Bisulfite modification of immobilized DNAs for methylation detection

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Gel immobilization of acrylamide-modified single-stranded DNA template for pyrosequencing.

1 reference

https://api.crossref.org/works/10.7785%2FTCRT.2012.500337

21 January 2018

Identifiers

10.7785/TCRT.2012.500337

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34686858&oldid=1956699122"